Vyluma pipeline focuses on refractive error

Video

Vyluma, which recently spun off from Nevakar, has a robust pipeline for potential therapies addressing refractive error. Navneet Puri, PhD, the company’s founder, chairman, and CEO, offers additional insights.

Recent Videos
Dr. Mark Bullimore investigates myopia in an omnibus model at AAOpt 2024
Pediatric optometrist Dr. Magdela Stec speaks about myopia management at EyeCon 2024
Dr Adam Wenick at EyeCon 2024
Brianna Rhue, OD, FAAO, FSLS, talks myopia management at Vision Expo West 2024
Mandy Sallach of Johnson & Johnson speaks on initiatives to combat pediatric myopia
Drs Tracy Schroeder Swartz and Clark Chang overview their keratoconus talk at Optometry's Meeting
David A. Berntsen, OD, PhD, FAAO, outlines his presentation on the BLINK 2 study presented at the 2024 ARVO meeting
© 2024 MJH Life Sciences

All rights reserved.